So as the main mechanism underlying G1-targeted CDK4/6 inhibitors go through avoiding RB1 tumor suppressor phosphorylation and its subsequent inactivation, the effects of some agents such as palbociclib require the presence of a functional pRb protein to work properly [188]. Here, CDK4 is linked to neoplasm.